Matches in Wikidata for { <http://www.wikidata.org/entity/Q63811381> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q63811381 description "clinical trial" @default.
- Q63811381 description "ensayu clínicu" @default.
- Q63811381 description "klinisch onderzoek" @default.
- Q63811381 description "клінічне випробування" @default.
- Q63811381 name "Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042" @default.
- Q63811381 type Item @default.
- Q63811381 label "Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042" @default.
- Q63811381 prefLabel "Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042" @default.
- Q63811381 P1132 Q63811381-DAE985C5-812A-4068-A4CE-35BD397EB37B @default.
- Q63811381 P1476 Q63811381-02E1B9EB-ECE7-4916-AB53-2C98C1EFA353 @default.
- Q63811381 P17 Q63811381-EEC2A2E0-8115-40DB-AE79-0DAF186FF5C4 @default.
- Q63811381 P2899 Q63811381-605AC6FA-8D4E-4166-A63D-6CA5A4B73581 @default.
- Q63811381 P3098 Q63811381-00321893-5BB5-47A9-A4D0-BA9F72B8B41F @default.
- Q63811381 P31 Q63811381-9DCD597B-6EB1-4EBD-941D-794C6EE9CF7E @default.
- Q63811381 P4844 Q63811381-399464CF-AD1F-42E3-B776-37C61591387D @default.
- Q63811381 P4844 Q63811381-7A0EC79C-9735-4D76-A3C7-3410FFE14155 @default.
- Q63811381 P4844 Q63811381-A4DF308F-C226-41D7-A45F-7FF5EF18B390 @default.
- Q63811381 P4844 Q63811381-BAC0E899-2F9B-41D1-B402-F4B5D518722D @default.
- Q63811381 P4844 Q63811381-F1F00D74-C393-4E53-B51C-79671A5DC382 @default.
- Q63811381 P580 Q63811381-F74FBEF4-38B6-40D1-9869-3BDD5DB63BE6 @default.
- Q63811381 P582 Q63811381-BDF64E09-6DF6-4424-B40F-CD8DF2E50702 @default.
- Q63811381 P6099 Q63811381-C97C7C97-4B62-47C8-BF1D-6C42A11D14D8 @default.
- Q63811381 P6153 Q63811381-497B19FC-1E46-46B5-87EB-0A3EA633A968 @default.
- Q63811381 P8363 Q63811381-8FBD5A02-2111-4D0D-AC2B-A9ECB5E5BF1A @default.
- Q63811381 P1132 "+168" @default.
- Q63811381 P1476 "Phase 1b Dose-Finding Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 in Patients With Advanced or Metastatic Cancer" @default.
- Q63811381 P17 Q30 @default.
- Q63811381 P2899 "+18" @default.
- Q63811381 P3098 "NCT03307785" @default.
- Q63811381 P31 Q30612 @default.
- Q63811381 P4844 Q25326660 @default.
- Q63811381 P4844 Q413299 @default.
- Q63811381 P4844 Q415220 @default.
- Q63811381 P4844 Q415588 @default.
- Q63811381 P4844 Q423762 @default.
- Q63811381 P580 "2017-10-12T00:00:00Z" @default.
- Q63811381 P582 "2019-11-01T00:00:00Z" @default.
- Q63811381 P6099 Q5452194 @default.
- Q63811381 P6153 Q212322 @default.
- Q63811381 P8363 Q78089383 @default.